# Roohi Jeelani

> Roohi Jeelani, MD, FACOG, is a Chicago-based reproductive endocrinologist, clinical researcher, educator, and Founder and CEO of Onto Health. After medical training at Ross University and Wayne State University, she moved from academic research into clinical leadership at Vios Fertility and Kindbody, built a large public education platform, and in 2026 took the helm of Onto Health. The company opened in Chicago, raised a $20 million Series A, and acquired LEVY Health as Jeelani pursued a more continuous, technology-enabled model of specialty care.

- **Role:** Founder and Chief Executive Officer at Onto Health
- **Organizations:** Onto Health, Kindbody, Vios Fertility Institute, Wayne State University, Detroit Medical Center, Ross University School of Medicine, Reproductive Genetics Institute, ResetOne
- **Education:** MD, Ross University School of Medicine, Residency in Obstetrics and Gynecology, Wayne State University / Detroit Medical Center, Fellowship in Reproductive Endocrinology and Infertility, Wayne State University
- **Known for:** Founded and leads Onto Health as CEO., Raised a $20 million Series A for Onto Health in April 2026., Led Onto Health's acquisition of LEVY Health in July 2026.

## Career timeline

- **2010** — Graduated from Ross University School of Medicine.
- **2010s** — Completed OB-GYN residency and a fellowship in reproductive endocrinology and infertility at Wayne State University / Detroit Medical Center.
- **2010s** — Served as an NIH Women's Reproductive Health Research Scholar and received K12 grant support.
- **2010s-2021** — Practiced at Vios Fertility Institute in Chicago and contributed to clinical research and education.
- **2021** — Joined the expanded Kindbody leadership team as Chief Clinical Research Officer following the Kindbody-Vios combination.
- **2025** — Announced an advisory role at ResetOne focused on reproductive endocrinology.
- **2026-01** — Named Founder and CEO of Onto Health as the company opened its Chicago location.
- **2026-04** — Onto Health closed a $20 million Series A funded by ARTIS and Humania.
- **2026-07** — Onto Health acquired clinical decision-support company LEVY Health.

## Achievements

- Founded and leads Onto Health as CEO.
- Raised a $20 million Series A for Onto Health in April 2026.
- Led Onto Health's acquisition of LEVY Health in July 2026.
- Double board-certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility.
- Served as an NIH Women's Reproductive Health Research Scholar with K12 grant support.
- Published articles in peer-reviewed medical journals, including work on physician advocacy and burnout.
- Received a Pacific Coast Reproductive Society Outstanding Paper second-place award.
- Built a large public education audience across social platforms.

## Latest updates

- **2026-07** — Onto Health acquired LEVY Health, adding clinical decision-support and intake technology to its platform.
- **2026-07** — Jeelani appeared on Inside Reproductive Health in a discussion about physicians building public media brands.
- **2026-07** — Jeelani appeared on The Mami Collective podcast to discuss her career, Onto Health, and leadership.
- **2026-04** — Onto Health announced a $20 million Series A funded by ARTIS and Humania to support U.S. and Gulf-region expansion.
- **2026-01** — Onto Health named Jeelani Founder and CEO and announced its Chicago expansion.

## Links

- Website: https://onto.health
- LinkedIn: https://www.linkedin.com/in/roohijeelanimd
- Instagram: https://www.instagram.com/roohijeelanimd/

---

Profile page: https://yespress.io/roohi-jeelani
Published by YesPress — https://yespress.io
Last updated: 2026-08-27